Contrast Enhanced Ultrasound Industry Overview
The global contrast enhanced ultrasound market size is estimated to reach USD 2.71 billion by 2028, expanding at a CAGR of 4.0%, according to a new report by Grand View Research, Inc. Introduction of affordable dyes, increasing sonography procedural volume, and contrast imaging modes becoming an integral feature of ultrasound systems are the prominent factors driving the market.
The increasing prevalence of cardiovascular diseases, liver lesions, renal lesions, gastrointestinal diseases, and vascular diseases globally is anticipated to boost the market growth, as these are major areas of clinical application of Contrast-enhanced Ultrasound (CEUS) systems.
Contrast Enhanced Ultrasound Market Segmentation
Grand View Research has segmented the global contrast-enhanced ultrasound market on the basis of product, type, end-use, and region:
Based on the Products Insights, the market is segmented into Equipment and Contrast Agent
- In 2020, the equipment segment dominated the product segment with a market share of 72.6%.
- The contrast agents segment is expected to grow at the fastest rate of 4.0% during the forecast period owing to its approval of usage in the liver and pediatric imaging by the FDA
Based on the Type Insights, the market is segmented into Non-targeted and Targeted
- In 2020, the non-targeted type segment dominated the CEUS market with a revenue share of over 73%.
- The increasing prevalence of chronic illnesses, such as liver cirrhosis, cancer, and CVDs, is the key factor expected to propel market growth.
Based on the End-use Insights, the market is segmented into Hospitals, Clinics, and Ambulatory Diagnostic Centers
- The hospitals segment dominated the market and accounted for the largest revenue share of more than 58% in 2020.
- The availability of specialist doctors and technicians in hospitals possessing skills in handling equipment & contrast agent is anticipated to fuel segment growth over the forecast years.
Contrast Enhanced Ultrasound Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Key Companies Profile & Market Share Insights
The key players are adopting various business strategies, such as mergers & acquisitions, product launches, joint ventures, and partnerships, to strengthen their presence in the global market.
Some prominent players in the global Contrast Enhanced Ultrasound market include:
- Lantheus Medical Imaging, Inc.
- Bracco Diagnostic Inc.
- General Electric
- Siemens Healthcare GmbH
- nanoPET Pharma GmbH
- ESAOTE SpA
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Order a free sample PDF of the Contrast Enhanced Ultrasound Market Intelligence Study, published by Grand View Research.
No comments:
Post a Comment